Access 2.8M+ Filings Sign Up Free
Philogen Logo

Philogen | PHIL - Profile, Filings, Stock Info & Investor Relations Data

Philogen | PHIL
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Italy
Founded
1996
Philogen (PHIL)

Company Profile

Website
Investor Relations

About Philogen

Founded in 1996, Philogen is an Italian-Swiss biotechnology company engaged in the discovery and development of biopharmaceutical products for the treatment of life-threatening conditions.

Philogen Group mainly discovers and develops targeted anti-cancer drugs, exploiting high-affinity ligands for tumor markers. These ligands – namely human monoclonal antibodies or small molecules – are identified through Antibody Phage Display Libraries and DNA-Encoded Chemical Libraries technologies. The main therapeutic strategy of the Group for the treatment of these diseases is the so-called “tumor targeting”.

Headquarters

PIAZZA LA LIZZA, 7
53100, SIENA
Italy

Philogen (PHIL)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Philogen (PHIL)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Philogen (PHIL)
Stock & Investor Information

ISINs

IT0005373789
IT0005373821

LEI

81560009EA1577917768

Stock Exchange Listings

Euronext Milan

Industry Classification

Sector
Health Care
Industry
Biotechnology